Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 72651 - 72675 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	RPA4	29935	upregulated	Silicon Dioxide analog results in increased expression of RPA4 mRNA	Xq21.33	A24195
Silicon dioxide	Approved	RPARP-AS1	100505761	downregulated	Silicon Dioxide results in decreased expression of RPARP-AS1 mRNA	10q24.32	A24196
Silicon dioxide	Approved	RPF2	84154	upregulated	Silicon Dioxide analog results in increased expression of RPF2 mRNA	6q21	A24195
Silicon dioxide	Approved	RPGRIP1	57096	downregulated	Silicon Dioxide analog results in decreased expression of RPGRIP1 mRNA	14q11.2	A24195
Silicon dioxide	Approved	RPH3AL	9501	downregulated	Silicon Dioxide analog results in decreased expression of RPH3AL mRNA	17p13.3	A24195
Silicon dioxide	Approved	RPH3AL	9501	downregulated	Silicon Dioxide results in decreased expression of RPH3AL mRNA	17p13.3	A24196
Silicon dioxide	Approved	RPL15	6138	upregulated	Silicon Dioxide results in increased expression of RPL15 mRNA	3p24.2	A24196
Silicon dioxide	Approved	RPL22L1	200916	upregulated	Silicon Dioxide analog results in increased expression of RPL22L1 mRNA	3q26.2	A24195
Silicon dioxide	Approved	RPL23AP32	56969	upregulated	Silicon Dioxide analog results in increased expression of RPL23AP32 mRNA	2p16.2	A24195
Silicon dioxide	Approved	RPL27A	6157	upregulated	Silicon Dioxide analog results in increased expression of RPL27A mRNA	11p15	A24195
Silicon dioxide	Approved	RPP40	10799	upregulated	Silicon Dioxide analog results in increased expression of RPP40 mRNA	6p25.1	A24195
Silicon dioxide	Approved	RPRML	388394	upregulated	Silicon Dioxide analog results in increased expression of RPRML mRNA	17q21.32	A24195
Silicon dioxide	Approved	RPS6KA3	6197	downregulated	Silicon Dioxide analog results in decreased expression of RPS6KA3 mRNA	Xp22.12	A24195
Silicon dioxide	Approved	RPS6KA4	8986	upregulated	Silicon Dioxide analog results in increased expression of RPS6KA4 mRNA	11q13.1	A24195
Silicon dioxide	Approved	RPS6KA5	9252	upregulated	Silicon Dioxide analog results in increased expression of RPS6KA5 mRNA	14q32.11	A24195
Silicon dioxide	Approved	RPS6KL1	83694	upregulated	Silicon Dioxide analog results in increased expression of RPS6KL1 mRNA	14q24.2	A24195
Silicon dioxide	Approved	RRAD	6236	upregulated	Silicon Dioxide analog results in increased expression of RRAD mRNA	16q22.1	A24194 A24195
Silicon dioxide	Approved	RRAD	6236	upregulated	Silicon Dioxide results in increased expression of RRAD mRNA	16q22.1	A24196
Silicon dioxide	Approved	RRAGB	10325	downregulated	Silicon Dioxide analog results in decreased expression of RRAGB mRNA	Xp11.21	A24195
Silicon dioxide	Approved	RRAGC	64121	upregulated	Silicon Dioxide analog results in increased expression of RRAGC mRNA	1p34.3	A24195
Silicon dioxide	Approved	RRAGD	58528	upregulated	Silicon Dioxide analog results in increased expression of RRAGD mRNA	6q15	A24195
Silicon dioxide	Approved	RRBP1	6238	downregulated	Silicon Dioxide analog results in decreased expression of RRBP1 mRNA	20p12.1	A24195
Silicon dioxide	Approved	RRM2	6241	downregulated	Silicon Dioxide analog results in decreased expression of RRM2 mRNA	2p25.1	A24194
Silicon dioxide	Approved	RRM2	6241	upregulated	Silicon Dioxide analog results in increased expression of RRM2 mRNA	2p25.1	A24195
Silicon dioxide	Approved	RRM2	6241	downregulated	Silicon Dioxide results in decreased expression of RRM2 mRNA	2p25.1	A24196

Displaying entries 72651 - 72675 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability